Long-term Outcomes of Injection Drug-related Infective Endocarditis Among People Who Inject Drugs
Authors:
- Joji SuzukiJSJoji Suzuki
- Jennifer A. JohnsonJJJennifer A. Johnson
- Mary W. MontgomeryMMMary W. Montgomery
- Margaret C. Mphil HaydenMHMargaret C. Mphil Hayden
- Christin N. PriceCPChristin N. Price
- Daniel A. SolomonDSDaniel A. Solomon
- Jane M. LiebschutzJLJane M. Liebschutz
- Jeffrey L. SchnipperJSJeffrey L. Schnipper
- Roger D. WeissRWRoger D. Weiss
- 18 October 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Addiction Medicine
- Vol. 14 (4) , 282-286
Abstract
Objectives: Infective endocarditis (IE) among people who inject drugs is associated with high rates of mortality and repeat episodes of endocarditis. We sought to report on longer-term clinical outcomes of patients with IE who were offered buprenorphine or methadone treatment for opioid use disorder (OUD) at their initial hospital admission. Methods: Individuals with OUD hospitalized between 2013 and 2015 with IE were included for the retrospective study. The following data were extracted from the medical record: sociodemographic data, mortality, repeat episodes of endocarditis, and evidence of ongoing buprenorphine and methadone treatment. The impact of medication use on mortality and repeat episode of endocarditis was examined using survival analysis. Results: Overall, 26 individuals were included in the study. The mean duration of follow-up was 45.0 months (SD 7.2, range 34.0–56.0). During the index admission, 8 received buprenorphine, 8 received methadone, and 10 declined medications. During the follow-up period, 4 (15.4%) individuals died and 10 (38.5%) individuals experienced a repeat episode of endocarditis. Survival analysis of mortality (log-rank P = 0.066) and repeat episode of endocarditis (log-rank P = 0.86) comparing those who received buprenorphine, received methadone, and declined medication did not differ significantly. Conclusions: Initiation of medication treatment alone may not be sufficient to impact long-term mortality and rates of repeat episode of endocarditis. More research is needed to identify optimal treatment strategies for people who inject drugs with IE.Keywords
This publication has 13 references indexed in Scilit:
- Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With MortalityAnnals of Internal Medicine, 2018
- Addiction consultation services – Linking hospitalized patients to outpatient addiction treatmentJournal of Substance Abuse Treatment, 2017
- Inpatient Addiction Consultation for Hospitalized Patients Increases Post-Discharge Abstinence and Reduces Addiction SeverityJournal of General Internal Medicine, 2017
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studiesBMJ, 2017
- Putting Parity into Practice — Integrating Opioid-Use Disorder Treatment into the Hospital SettingNew England Journal of Medicine, 2016
- Surgical outcomes of infective endocarditis among intravenous drug usersThe Journal of Thoracic and Cardiovascular Surgery, 2016
- Hospitalizations Related To Opioid Abuse/Dependence And Associated Serious Infections Increased Sharply, 2002–12Health Affairs, 2016
- Medication‐assisted treatment for hospitalized patients with intravenous‐drug‐use related infective endocarditisThe American Journal on Addictions, 2016
- Long-Term Outcome for the Surgical Treatment of Infective Endocarditis With a Focus on Intravenous Drug UsersThe Annals of Thoracic Surgery, 2012
- Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment.2006